Anorexia nervosa, obsessional behavior, and serotonin
- PMID: 9550876
Anorexia nervosa, obsessional behavior, and serotonin
Abstract
Although many women diet, relatively few develop the extreme weight loss and the clinical symptoms of anorexia nervosa. An underlying biological diathesis and temperament may place someone at risk for developing anorexia nervosa. Certain traits, such as negative affect, behavioral inhibition, compliance, high harm avoidance, and an obsessive concern with symmetry, exactness, and perfectionism, persist after recovery from anorexia nervosa. These persistent symptoms raise the possibility that such traits exist premorbidly and contribute to the pathogenesis of this disorder. Such traits could be associated with increased brain serotonin activity. After recovery, anorexics have increased levels of 5-HIAA, the major metabolite of serotonin, in the cerebrospinal fluid (CSF). Low CSF 5-HIAA levels have been associated with impulsive and aggressive behaviors, which are opposite to those typically found in anorexia nervosa. Increased serotonin activity could contribute to many behavioral symptoms, such as increased satiety. Moreover, recent data suggest that selective serotonin reuptake inhibitor (SSRI)-type medication improves outcome and prevents relapse in people with anorexia nervosa. These theoretical issues have important clinical implications in this era of diminished support for treatment of eating disorders. Anorexia nervosa, like other major psychiatric disorders, has contributory pathophysiology and can benefit from and deserves appropriate treatment resources.
Similar articles
-
Serotonin activity in anorexia and bulimia nervosa: relationship to the modulation of feeding and mood.J Clin Psychiatry. 1991 Dec;52 Suppl:41-8. J Clin Psychiatry. 1991. PMID: 1752859 Review.
-
Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa.Biol Psychiatry. 1995 Apr 15;37(8):504-11. doi: 10.1016/0006-3223(94)00169-4. Biol Psychiatry. 1995. PMID: 7619973 Clinical Trial.
-
Research update on serotonin function in bulimia nervosa and anorexia nervosa.Psychopharmacol Bull. 1997;33(3):345-54. Psychopharmacol Bull. 1997. PMID: 9550877 Review.
-
Cause and treatment of anorexia nervosa.Physiol Behav. 2007 Sep 10;92(1-2):283-90. doi: 10.1016/j.physbeh.2007.05.052. Epub 2007 May 25. Physiol Behav. 2007. PMID: 17585973 Review.
-
An open trial of fluoxetine in patients with anorexia nervosa.J Clin Psychiatry. 1991 Nov;52(11):464-71. J Clin Psychiatry. 1991. PMID: 1744064 Clinical Trial.
Cited by
-
Exercise and eating disorder symptoms among young females.Eat Weight Disord. 2001 Mar;6(1):32-9. doi: 10.1007/BF03339749. Eat Weight Disord. 2001. PMID: 11300543
-
Embryonic Exposure to Tryptophan Yields Bullying Victimization via Reprogramming the Microbiota-Gut-Brain Axis in a Chicken Model.Nutrients. 2022 Feb 4;14(3):661. doi: 10.3390/nu14030661. Nutrients. 2022. PMID: 35277020 Free PMC article.
-
The integration of primary anorexia nervosa and obsessive-compulsive disorder.Eat Weight Disord. 2001 Dec;6(4):174-80. doi: 10.1007/BF03339740. Eat Weight Disord. 2001. PMID: 11808812 Review.
-
A Pilot Study of an Acceptance-Based Separated Family Treatment for Adolescent Anorexia Nervosa.Cogn Behav Pract. 2013 Nov;20(4):485-500. doi: 10.1016/j.cbpra.2012.11.001. Cogn Behav Pract. 2013. PMID: 27307691 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical